Similar articles for PMID: 25376902

Year	Number of Results
2004	3
2005	6
2006	4
2007	4
2008	9
2009	4
2010	1
2011	8
2012	5
2013	5
2014	13
2015	22
2016	7
2017	2
2019	1
2020	1
2022	1
2023	2
2024	0

1

Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation.

Kawaoka T, Takahashi S, Kawakami Y, Tsuge M, Hiramatsu A, Imamura M, Hyogo H, Aikata H, Ishiyama K, Tashiro H, Ohdan H, Tanaka J, Chayama K. Kawaoka T, et al. Hepatol Res. 2015 Nov;45(11):1047-54. doi: 10.1111/hepr.12447. Epub 2014 Dec 2. Hepatol Res. 2015. PMID: 25376902

2

High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.

Faisal N, Mumtaz K, Marquez M, Renner EL, Lilly LB. Faisal N, et al. Hepatol Int. 2015 Jan;9(1):76-83. doi: 10.1007/s12072-014-9589-6. Epub 2014 Nov 29. Hepatol Int. 2015. PMID: 25788382

3

Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.

Sharma P, Marrero JA, Fontana RJ, Greenson JK, Conjeevaram H, Su GL, Askari F, Sullivan P, Lok AS. Sharma P, et al. Liver Transpl. 2007 Aug;13(8):1100-8. doi: 10.1002/lt.21121. Liver Transpl. 2007. PMID: 17377914 Free article.

4

Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.

Lodato F, Berardi S, Gramenzi A, Mazzella G, Lenzi M, Morelli MC, Tame MR, Piscaglia F, Andreone P; Bologna Liver Transplantation Group (BLTG); Ballardini G, Bernardi M, Bianchi FB, Biselli M, Bolondi L, Cescon M, Colecchia A, D'Errico A, Del Gaudio M, Ercolani G, Grazi GL, Grigioni W, Lorenzini S, Pinna AD, Ravaioli M, Roda E, Sama C, Vivarelli M. Lodato F, et al. Aliment Pharmacol Ther. 2008 Aug 15;28(4):450-7. doi: 10.1111/j.1365-2036.2008.03761.x. Epub 2008 Jun 11. Aliment Pharmacol Ther. 2008. PMID: 18549463 Free article. Clinical Trial.

5

Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.

Hanouneh IA, Miller C, Aucejo F, Lopez R, Quinn MK, Zein NN. Hanouneh IA, et al. Liver Transpl. 2008 Jan;14(1):53-8. doi: 10.1002/lt.21312. Liver Transpl. 2008. PMID: 18161839 Free article.

6

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J. Shepherd J, et al. Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. doi: 10.3310/hta8390. Health Technol Assess. 2004. PMID: 15461877 Free article. Review.

7

Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation.

Kawaoka T, Takahashi S, Tatsukawa Y, Hiramatsu A, Hiraga N, Miki D, Tsuge M, Imamura M, Kawakami Y, Aikata H, Ochi H, Ishiyama K, Ide K, Tashiro H, Ohdan H, Chayama K. Kawaoka T, et al. Hepatol Res. 2014 Nov;44(12):1259-64. doi: 10.1111/hepr.12296. Epub 2014 Feb 17. Hepatol Res. 2014. PMID: 24382214

8

OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.

Bruno R, Cariti G, Nasta P, Capetti A, Ravasio V, Galli M, Raise E, Palmieri G, Iannacone C, Puoti M. Bruno R, et al. Liver Int. 2015 Jan;35(1):120-9. doi: 10.1111/liv.12641. Epub 2014 Aug 11. Liver Int. 2015. PMID: 25041136 Clinical Trial.

9

Sustained virological response of patients with hepatitis C virus genotype 2 depends on pegylated interferon compliance.

Watanabe T, Konishi I, Shigematsu S, Uesugi K, Joko K, Seike H, Okada S, Miyaoka H, Nakanishi S, Abe M, Matsuura B, Michitaka K, Horiike N, Hiasa Y, Onji M. Watanabe T, et al. Hepatol Res. 2011 Aug;41(8):722-30. doi: 10.1111/j.1872-034X.2011.00816.x. Epub 2011 Jun 17. Hepatol Res. 2011. PMID: 21682826

10

Sustained virological response rates to antiviral therapy in genotype 1 and 3 chronic hepatitis C patients: a study from north India.

Gupta V, Kumar A, Sharma P, Tyagi P, Bansal N, Singla V, Arora A. Gupta V, et al. J Clin Exp Hepatol. 2014 Dec;4(4):287-92. doi: 10.1016/j.jceh.2014.08.004. Epub 2014 Sep 16. J Clin Exp Hepatol. 2014. PMID: 25755575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year